Forecast of new brand and LOE impact in developed pharma markets 2019-2026

Forecast of new brand and brand loss of exclusivity (LOE) impact in developed pharmaceutical markets from 2019 to 2026

Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

December 2021

Region

Worldwide

Survey time period

as of November 2021

Supplementary notes

Developed markets include: U.S., Japan, Germany, France, Italy, U.K., Spain, Canada, S.Korea, Australia; LOE = loss of exclusivity.
All values are rounded estimates/forecasts and in constant U.S. dollars.

Citation formats
Statista Accounts: Access All Statistics. Starting from $2,388 USD / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Starter Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$199 USD / Month *
Professional Account
Full access

Business Solutions including all features.

* Prices do not include sales tax.

Statistics on " Generics and biosimilars "

Other statistics that may interest you Generics and biosimilars

Global overview

4

Top companies

4

U.S. market

6

Patent expiration

6

Savings

7

Biosimilars

7

Further related statistics

17
Statista Accounts: Access All Statistics. Starting from $2,388 USD / Year
Learn more about how Statista can support your business.